stimOS GmbH, a Constance, Germany-based developer of patented Mimicking Bone Technology (MBT), raised €720k in seed funding.
Backers included High-Tech Gründerfonds, MBG, and Baden-Württemberg (MBG).
The company intends to use the funds for further development and approval of its technology.
Founded in May 2015 by Prof. Dr. Helmut Cölfen, Prof. Dr. Günter Schatz, Prof. Dr. Johannes Boneberg, all from the University of Constance, and Dr. Dietmar Schaffarczyk, CEO, stimOS has developed a biochemical procedure that initiates early and healthy bone formation, anti-inflammatory activity, and faster healing process to ensure best possible recovery for the patient and achieve a pain-free life after surgery.
Implants remain firmly anchored even in osteoporotic bone.